Cargando…

Analysis of cancer-promoting genes related to chemotherapy resistance in esophageal squamous cell carcinoma

BACKGROUND: According to histopathology, esophageal cancer can be divided into squamous cell carcinoma (SCC) and esophageal adenocarcinoma (adeno arcinoma). In China, 90% of esophageal cancer patients are squamous cell carcinoma. Cisplatin and fluaziridine are the main chemotherapy before and after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Feng, Zhang, Donglei, Qian, Xiaoqing, Wei, Huabing, Zhou, Lihuang, Ding, Chunyong, Pan, Wenbiao, Ye, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848450/ https://www.ncbi.nlm.nih.gov/pubmed/35282117 http://dx.doi.org/10.21037/atm-21-7032

Ejemplares similares

Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma
por: Zhang, Donglei, et al.
Publicado: (2020)

The DMRTA1-SOX2 positive feedback loop promotes progression and chemotherapy resistance of esophageal squamous cell carcinoma
por: ZHANG, RUI, et al.
Publicado: (2023)

Linc01614 Regulates the Proliferation, Apoptosis, and Chemotherapy Resistance in Esophageal Squamous Cell Carcinoma by Targeting Mir-4775
por: Wei, Wei, et al.
Publicado: (2023)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
por: Zhang, Qingyi, et al.
Publicado: (2019)

Self-renewal and chemotherapy resistance of p75(NTR )positive cells in esophageal squamous cell carcinomas
por: Huang, Sheng-Dong, et al.
Publicado: (2009)

MLL3 promotes the senescence of esophageal squamous cell carcinoma
por: Xia, Manhui, et al.
Publicado: (2019)

Circ-DLG1 promotes the proliferation of esophageal squamous cell carcinoma
por: Rong, Jun, et al.
Publicado: (2018)

Network-Based Pharmacological Study on the Mechanism of Action of Buxue Liqi Huatan Decoction in the Treatment of Lung Cancer
por: Wei, Huabing, et al.
Publicado: (2022)

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma
por: van Laarhoven, Hanneke W.M., et al.
Publicado: (2023)

Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma
por: Chen, Qiuyu, et al.
Publicado: (2023)

Promoting role of pentraxin-3 in esophageal squamous cell carcinoma
por: Fan, Zhirui, et al.
Publicado: (2022)

Complex Epigenetic Regulation of Chemotherapy Resistance and Biology in Esophageal Squamous Cell Carcinoma via MicroRNAs
por: Lindner, Kirsten, et al.
Publicado: (2018)

miR-4443 promotes radiation resistance of esophageal squamous cell carcinoma via targeting PTPRJ
por: Shi, Xiaobo, et al.
Publicado: (2022)

Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma
por: Li, Ji-Sheng, et al.
Publicado: (2013)

Trafficking protein TMED3 promotes esophageal squamous cell carcinoma
por: Yang, Yuxian, et al.
Publicado: (2023)

Circ-TTC17 Promotes Proliferation and Migration of Esophageal Squamous Cell Carcinoma
por: Wang, Qian, et al.
Publicado: (2018)

Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells
por: DANG, LIFENG, et al.
Publicado: (2014)

Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma
por: Pao, Tzu-Hui, et al.
Publicado: (2021)

NSG1 promotes glycolytic metabolism to enhance Esophageal squamous cell carcinoma EMT process by upregulating TGF-β
por: Tu, Mingshu, et al.
Publicado: (2023)

Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy
por: Shi, Qi, et al.
Publicado: (2018)

Targeting CDC7 improves sensitivity to chemotherapy of esophageal squamous cell carcinoma
por: Cao, Ji-Xiang, et al.
Publicado: (2018)

Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
por: Wu, Zhigang, et al.
Publicado: (2021)

Esophageal mycobiome landscape and interkingdom interactions in esophageal squamous cell carcinoma
por: Rao, Wen-Qing, et al.
Publicado: (2023)

The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study
por: He, Hongbo, et al.
Publicado: (2022)

Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
por: Fang, Shuogui, et al.
Publicado: (2022)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
por: Chen, Mingqiu, et al.
Publicado: (2018)

DNAJB6 Promotes Ferroptosis in Esophageal Squamous Cell Carcinoma
por: Jiang, Bin, et al.
Publicado: (2019)

Long non-coding RNA LINC00491 promotes proliferation and inhibits apoptosis in esophageal squamous cell carcinoma
por: Ye, Hui, et al.
Publicado: (2021)

DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation
por: Su, Zhenzi, et al.
Publicado: (2021)

Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3
por: Zhao, Lei, et al.
Publicado: (2012)

Cost-Effectiveness Analysis of Camrelizumab vs. Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
por: Zhang, Qilin, et al.
Publicado: (2021)

The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma
por: Zhao, Zheng, et al.
Publicado: (2023)

Risk Factors Associated with Esophageal Fistula after Radiotherapy for Esophageal Squamous Cell Carcinoma
por: Hu, Bing, et al.
Publicado: (2020)

Clinical value of hematologic test in predicting tumor response to neoadjuvant chemotherapy with esophageal squamous cell carcinoma
por: Liu, Yinan, et al.
Publicado: (2014)

Cripto-1 Promotes the Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Cells
por: Huang, Chun, et al.
Publicado: (2015)

Efficacy of postoperative adjuvant chemotherapy for esophageal squamous cell carcinoma: A meta‐analysis
por: Zhao, Peiliang, et al.
Publicado: (2018)

Effect of Body Composition Change during Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Onishi, Sachiyo, et al.
Publicado: (2022)

Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
por: Lv, Huilai, et al.
Publicado: (2022)

Proton Pump Inhibitors Enhance the Antitumor Effect of Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Matsumura, Shinya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_usu072eee2drd3jq5vlogppbpk